NEWB

COM:NEWBURYPHARMA

Newbury Pharma

  • Stock

SEK

Last Close

3.32

25/11 08:40

Market Cap

91.21M

Beta: -

Volume Today

4.70K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Aug '21
Aug '22
Aug '23
Aug '24
net income
-5.56M
-
-14.67M
163.94%
-19.43M
32.48%
-13.89M
28.54%
depreciation and amortization
1.01M
-
1.25M
24.75%
deferred income tax
stock based compensation
148K
-
68K
54.05%
change in working capital
884K
-
-1.36M
254.19%
-5.37M
294.06%
-9.82M
82.85%
accounts receivables
inventory
-1.77M
-
-331K
81.34%
accounts payables
other working capital
-9.82M
-
other non cash items
279K
-
net cash provided by operating activities
-4.07M
-
-15.00M
268.94%
-23.23M
54.84%
-23.71M
2.07%
investments in property plant and equipment
-23.09M
-
-24.40M
5.68%
-862K
96.47%
acquisitions net
purchases of investments
-3.65M
-
sales maturities of investments
other investing activites
-2.95M
-
net cash used for investing activites
-26.73M
-
-24.40M
8.74%
-862K
96.47%
-2.95M
242.69%
debt repayment
-14.64M
-
-717K
95.10%
common stock issued
43.95M
-
44.95M
2.27%
common stock repurchased
dividends paid
other financing activites
33.44M
-
net cash used provided by financing activities
43.95M
-
59.59M
35.59%
-717K
101.20%
33.44M
4,763.32%
effect of forex changes on cash
net change in cash
13.14M
-
20.19M
53.59%
-24.81M
222.87%
6.78M
127.31%
cash at beginning of period
13.14M
-
33.33M
153.59%
8.53M
74.42%
cash at end of period
13.14M
-
33.33M
153.59%
8.53M
74.42%
15.30M
79.44%
operating cash flow
-4.07M
-
-15.00M
268.94%
-23.23M
54.84%
-23.71M
2.07%
capital expenditure
-23.09M
-
-24.40M
5.68%
-862K
96.47%
free cash flow
-27.15M
-
-39.40M
45.11%
-24.09M
38.86%
-23.71M
1.59%

All numbers in SEK (except ratios and percentages)